BioCentury
ARTICLE | Company News

MDxHealth, Takara Bio deal

December 6, 2010 8:00 AM UTC

Takara received a non-exclusive, worldwide license to use MDxHealth's methylation specific PCR ( MSP) technology as part of its research tools which are used to identify methylation patterns in cancer...